HILS   $0.2305  2.76% Market Closed

Hillstream Biopharma Inc
Total Cash 3.90M
totalCashPerShare 0.223
EBITDA
Total Debt 0.00
quickRatio 2.551
currentRatio 3.006
Total Revenue
debtToEquity
Revenue/Share
ROA -0.77971
ROE -1.47312
grossProfits
freeCashflow -4.28M
operatingCashflow -7.42M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 137.24K
forwardPE -1.5799999
floatShares 11.46M
sharesOutstanding 17.60M
sharesShort 52.74K
sharesShortPriorMonth 132.94K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.39%
heldPercentInstitutions 0.01%
Short Ratio help_outline 0.41%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 0.183
Price To Book help_outline 1.30
earningsQuarterlyGrowth
netIncomeToCommon -8.92M
trailingEps -0.70%
forwardEps -0.15%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.06 3Q 2023
institutionsCount 8
lastUpdated Nov. 14, 2023, 10:27 p.m.